responses of T eff cells versus those of T reg cells, or an inequity between proinflammatory signals and anti-inflammatory signals, can very easily evolve into an imbalance in immunological reactivity that can manifest as inflammatory bowel disease. Studies such as those presented here are central for advancing understanding of the intricate mechanisms involved in the 'preferential' migration of cells to target tissues and will be invaluable for helping identify ways to manipulate migration pathways as a method for treating autoimmune and inflammatory disease.
In summary, the study by Nguyen et al. 1 offers new insight into and direction for the development of novel therapies aimed at controlling dysregulated inflammation in the intestine in diseases such as ulcerative colitis. Caution will need to be exerted, and the judicious use of animal models will be an important consideration, given the major differences barrage of enormous antigenic onslaught. An important next step for furthering knowledge about GPR15 and the migration of T cells to the large intestine will be to identify the natural ligand(s) for GPR15, to see whether any additional insight can be gained into the control of the homing of T cells to the colon in human health and disease. Another important next step will be to identify the additional regulatory pathways that support the trafficking of the remaining T cell subsets to the large intestine, with particular emphasis on determining the similarities in and disparities between humans and mice in these mechanisms.
Precision in the trafficking of cells to the large intestine is of paramount importance for maintaining a healthy ecosystem in which tolerance to food and the commensal flora is necessary while retaining the ability to quickly deploy protective immunity in times of infection. Subtle immunological dysregulation in the PTENtiating autoimmunity through T reg cell deregulation
John P Ray & Joe Craft
Regulatory T cells require the phosphatase PTEN to maintain suppressive function in homeostatic conditions through preserved expression of CD25 and the transcription factor Foxp3. IL-2 is known to induce the differentiation and maintenance of T reg cells, signaling through the signal transducer STAT5 to maintain Foxp3 expression 4 . IL-2 signaling is also mediated by phosphatidylinositol-3-OH kinase (PI(3)K) and activation of the metabolic checkpoint kinase mTOR in effector T cells, such as the T H 1 and T H 17 subsets of helper T cells 5 ; however, the differentiation of T reg cells is not reliant upon signaling via this IL-2-dependent pathway (Fig. 1a) . T reg cells also do not upregulate glycolytic metabolism and instead 'preferentially' use fatty acids to promote their regulatory functions 6 . PTEN is a potent negative regulator of PI(3)K signaling, using its phosphatase activity to oppose PI(3)K-mediated conversion of the membrane-associated signaling molecule phosphatidylinositol-(4,5)-bisphosphate to phosphatidylinositol-(3,4,5)-trisphosphate 5 . In line with the role of PTEN in immunoregulation, deletion of PTEN in CD4 + T cells leads to thymus-derived lymphoma and autoimmunity, although the T cell subset-intrinsic role of PTEN in regulating autoimmunity is unclear 7 . PTEN has high expression in T reg cells and has been found to suppress the population expansion of T reg cells 8 . Huynh et al. 2 and Shrestha et al. 3 now demonstrate that PTEN in T reg cells is critical for the control of autoimmunity and find it is essential for maintaining the expression of CD25 and Foxp3 (Fig. 1b) .
As a consequence, T reg cell-intrinsic expression of PTEN is necessary for the suppression of autoimmune responses mediated by T H 1 cells and follicular helper T cells (T FH cells), which drive B cell maturation, via attenuation of production of the inflammatory cytokine interferon-γ (IFN-γ).
Both studies take a genetic deletion approach, generating T reg cells that are selectively deficient in PTEN by breeding mice with loxP-flanked Pten alleles to mice that express Cre recombinase driven by the Foxp3 promoter to generate Pten fl/fl Foxp3-Cre offspring. T reg cells lacking PTEN are more abundant than in non-mutant mice, as demonstrated before 8 ; however, these cells also have a marked reduction in cell surface expression of CD25, which leads both sets of authors to conclude that PTEN-deficient T reg cells convert into 'ex-T reg cells' , or cells that have lost Foxp3 expression and suppressor function. Lineage-tracing experiments 9 confirm this idea, with the demonstration that PTEN-deficient T reg cells do indeed lose Foxp3 expression while also losing the ability to suppress effector cells. Instead, PTEN-deficient ex-T reg cells upregulate expression of IFN-γ 9 . This increase in the effector function of T H 1 cells is a result of activation of the mTOR complex mTORc2, as Shrestha et al. find that deletion of the RICTOR subunit of this complex restores the phenotype of PTENdeficient T reg cells 3 .
In line with changes in the suppressor function of T reg cells, both sets of authors find qualitative globally deficient in PTEN. 3 support the rationale for blockade of IFN-γ in humans with SLE. Furthermore, their studies emphasize that deregulation of T reg cells might be a chief driver of systemic autoimmunity and, conversely, that their modulation or adoptive transfer might be beneficial. For example, rapamycin, known to promote the proliferation of T reg cells at the expense of that of effector cells, is therapeutically beneficial in SLE 12 , while transfer of T reg cells is efficacious in mouse models of lupus 13 . Similar approaches are being used in clinical trials of type 1 diabetes mellitus (http://clinicaltrials.gov/ct2/show/ NCT01210664?term= type+1+diabetes+and+ tregcells&rank = 1/). These clinical approaches highlight the broad implications of the findings of Huynh et al. 2 and Shrestha et al. 3 that PTEN is critical for the suppression of potentially pathogenic T cells by T reg cells in non-infectious conditions.
